Circulating primers enhance platelet function and induce resistance to antiplatelet therapy

24Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Aspirin and P2Y12 antagonists are antiplatelet compounds that are used clinically in patients with thrombosis. However, some patients are 'resistant' to antiplatelet therapy, which increases their risk of developing acute coronary syndromes. These patients often present with an underlying condition that is associated with altered levels of circulating platelet primers and platelet hyperactivity. Platelet primers cannot stimulate platelet activation, but, in combination with physiologic stimuli, significantly enhance platelet function. Objectives: To explore the role of platelet primers in resistance to antiplatelet therapy, and to evaluate whether phosphoinositide 3-kinase (PI3K) contributes to this process. Methods and Results: We used platelet aggregation, thromboxane A2 production and ex vivo thrombus formation as functional readouts of platelet activity. Platelets were treated with the potent P2Y12 inhibitor AR-C66096, aspirin, or a combination of both, in the presence or absence of the platelet primers insulin-like growth factor-1 (IGF-1) and thrombopoietin (TPO), or the Gz-coupled receptor ligand epinephrine. We found that platelet primers largely overcame the inhibitory effects of antiplatelet compounds on platelet functional responses. IGF-1-mediated and TPO-mediated, but not epinephrine-mediated, enhancements in the presence of antiplatelet drugs were blocked by the PI3K inhibitors wortmannin and LY294002. Conclusions: These results demonstrate that platelet primers can contribute to antiplatelet resistance. Furthermore, our data demonstrate that there are PI3K-dependent and PI3K-independent mechanisms driving primer-mediated resistance to antiplatelet therapy.

References Powered by Scopus

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study

3144Citations
N/AReaders
Get full text

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

1335Citations
N/AReaders
Get full text

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

833Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Platelet biology and functions: new concepts and clinical perspectives

701Citations
N/AReaders
Get full text

Platelet populations and priming in hematological diseases

61Citations
N/AReaders
Get full text

Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes

49Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Blair, T. A., Moore, S. F., & Hers, I. (2015). Circulating primers enhance platelet function and induce resistance to antiplatelet therapy. Journal of Thrombosis and Haemostasis, 13(8), 1479–1493. https://doi.org/10.1111/jth.13022

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

53%

Researcher 7

37%

Professor / Associate Prof. 2

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

68%

Biochemistry, Genetics and Molecular Bi... 4

18%

Pharmacology, Toxicology and Pharmaceut... 2

9%

Decision Sciences 1

5%

Save time finding and organizing research with Mendeley

Sign up for free